Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: A randomized open crossover trial

Pediatrics

Volumn 112, Issue 3 I, 2003, Pages 559-564

  Weintrob, Naomi ^a,b   Benzaquen, Hadassa ^a   Galatzer, Avinoam ^a   Shalitin, Shlomit ^b   Lazar, Liora ^b   Fayman, Gila ^a   Lilos, Pearl ^a   Dickerman, Zvi ^b   Phillip, Moshe ^b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Children; Continuous subcutaneous insulin infusion; Intensive therapy; Multiple daily insulin injections; Pump; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC KETOACIDOSIS; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; TREATMENT OUTCOME;

EID: 0042338756     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.112.3.559     Document Type: Article

References (27)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med. 1993;329:977-986
2. Kostraba JN, Dorman JS, Orchard TJ, et al. Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care. 1989;12:686-693
3. Shalitin S, Josefsberg Z, Lilos P, De-Vries L, Phillip M, Weintrob N. Bedside scoring procedure for the diagnosis of diabetic peripheral neuropathy in young patients with type 1 diabetes. J Pediatr Endocrinol Metab. 2002;15:613-620
4. Weissberg-Benchall J, Glasgow AM, Tynan WD, Wirtz P, Turck J, Ward J. Adolescent diabetes management and mismanagement. Diabetes Care. 1995;18:77-83
5. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr. 1994;125:177-188
6. Becker DJ, Ryan CM. Hypoglycemia. A complication of diabetes therapy in children. Trends Endocrinol Metab. 2000;11:198-202
7. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care. 1999;22:1779-1784
8. Johnson SB, Silverstein J, Rosenbloom A, Carter R, Cunningham W. Assessing daily management of childhood diabetes. Health Psychol. 1986;5:545-564
9. Wing RR, Nowalk MP, Marcus MD, Koeske R, Finegold D. Subclinical eating disorders and glycemic control in adolescents with type 1 diabetes. Diabetes Care. 1986;9:162-167
10. Diabetes Control and Complications Trial Research Group. Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care. 1995;18:361-376
11. Hanaire-Broutin H, Melki V, Bessieres-Lacombe S, Tauber JP, The Study Group for the Development of Pump Therapy in Diabetes. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment. Diabetes Care. 2000;23:1232-1235
12. Kaufman FR, Halvorson M, Kim C, Pitukcheewanont P. Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes. Diabetes Care. 2000;23:579-582
13. 1c in the diabetes control and complications trial. Diabetes Care. 2002;25:275-278
14. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM. CDC Growth Charts: United States Advance Data From Vital and Health Statistics. No. 314. Hyattsville, MD: National Center for Health Statistics; 2000
15. Bradley C. Diabetes Treatment Satisfaction Questionnaire (DTSQ). In: Bradley C, ed. Handbook of Psychology and Diabetes. Reading, United Kingdom: Gordon & Breach; 1994:111-132
16. Ingersoll GM, Marrero DG. A modified quality of life measure for youths: psychometric properties. Diabetes Educ. 1991;17:114-118
17. Dixon WJ, ed. BMDP Statistical Software. Los Angeles, CA: University of California Press; 1993
18. Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics. 2001;107:351-356
19. Schiffrin A, Belmonte MM. Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin; a one-year prospective study. Diabetes. 1982;31:255-264
20. Tsui E, Barnie A, Ross S, Parkes R, Zinman B. Intensive therapy with insulin lispro; a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. Diabetes Care. 2001;24:1722-1727
21. Scottish Study Group for the Care of the Young Diabetic. Factors influencing glycemic control in young people with type 1 diabetes in Scotland: a population-based study (DIABAUD2). Diabetes Care. 2001;24:239-244
22. Lalli C, Ciofetta M, Del Sindaco P, et al. Long-term intensive treatment of type I diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. Diabetes Care. 1991;22:468-477
23. Deeb LC, Holcombe JH, Brunelle R, et al. Insulin lispro lowers postprandial glucose in prepubertal children with diabetes. Pediatrics. 2001;108:1175-1179
24. Brunelle RL, Llewellyn J, Anderson Jr JH, Gale EAM, Koivisto VA. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care. 1998;21:1726-1731
25. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type 1 diabetes. Lancet. 1993;341:1306-1309
26. Couper JJ, Taylor J, Fotheringham MJ, Sawyer M. Failure to maintain the benefits of home-based intervention in adolescents with poorly controlled type 1 diabetes. Diabetes Care. 1999;22:1933-1937
27. Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of long-term complications: the perspective of the diabetes control and complications trial. Diabetes. 1996;45:1289-1298